Cholecystitis & Pregnancy - KSherafgan

download Cholecystitis & Pregnancy - KSherafgan

of 41

Transcript of Cholecystitis & Pregnancy - KSherafgan

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    1/41

    Cholecystitis &

    PregnancyKashaf Sherafgan, MD

    PGY-2, General Surgery

    Englewood HospitalDecember 21st 2005

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    2/41

    Case Presentation

    23-year-old woman, 16 weeks pregnant

    c/o abd pain x 2 days

    RUQ pain, radiating to back Nausea & vomiting

    Similar complaint X 3 over 2 months

    Last ER presentation 2 days ago

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    3/41

    Physical examination

    Afebrile

    Minimal scleral icterus

    Epigastric tenderness Positive Murphys sign

    Gravid uterus

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    4/41

    Laboratory workup

    WBC: 7400 (78.2% neutrophils)

    AST / ALT: 103 / 200

    Alk Phos: 128 T / D Bili: 3.5 / 1.9

    Amylase: 108

    Lipase: 106

    UA: Moderate bilirubin

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    5/41

    Ultrasound

    Small shadowing gallstone within GB

    No wall thickening

    No pericholecystic fluid No biliary dilatation

    CBD ~ 5 mm

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    6/41

    Ultrasound

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    7/41

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    8/41

    Clinical course

    NPO

    IV hydration

    Pain control

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    9/41

    Hospital course, cont.

    Day 2

    AST / ALT: 68 / 154

    Alk Phos: 98 T/D Bili: 2.1 / 1.8

    Amylase: 117

    Lipase: 135

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    10/41

    MRCP

    Multiple gallstones

    No evidence of biliary duct dilatation

    CBD ~ 5 mm No evidence of CBD stones or intraluminal

    filling defects

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    11/41

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    12/41

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    13/41

    Hospital course, cont.

    Day 5

    Pain on PO intake

    Increasing scleral icterus AST / ALT: 60 / 146

    Alk Phos: 102

    T/D Bili: 4.2 / 2.1

    Amylase: 149

    Lipase: 368

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    14/41

    Hospital course, cont:

    Day 7

    Laparoscopic cholecystectomy

    Findings Minimal adhesions

    Distended thin-walled GB

    Thick sludge

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    15/41

    Post-operative course

    Immediately post op:

    AST / ALT: 56 / 137

    Alk Phos: 134 T/D Bili: 3.0 / 2.0

    Amylase / Lipase: 1.3 / 127

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    16/41

    Post-op course, cont.

    POD #2

    AST / ALT: 36 / 97

    Alk Phos: 117 T/D Bili: 1.8 / 1.4

    Discharged home in stable condition

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    17/41

    Medical versus surgicalmanagement of biliary tract

    disease in pregnancyLu EJ et al

    American J of Surg 2004;188:755

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    18/41

    Methods

    Retrospective multicenter studyCompared maternal and fetal

    outcomes of medical vs surgicalmanagement Impact of complications of gallstone

    disease, including gallstone

    pancreatitis and choledocholithiasis,on fetal outcome

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    19/41

    Results

    76 women with 78 pregnancies were admittedwith biliary tract disease

    63 presented with symptomatic cholelithiasis, 10

    underwent surgery while pregnant No deaths, preterm deliveries, or ICU admissions

    53 treated medically Courses complicated by symptomatic relapse in 20

    patients (38%), labor induction to control biliary colic (8patients) and by premature delivery in 2 patients

    Each relapse in the medically managed group accountedfor an additional five days in hospital

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    20/41

    Clinical presentation

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    21/41

    Management

    Initially conservative management IVF

    NPO

    Narcotics Antibiotics

    Surgery performed for patients with Refractory pain

    Deteriorating clinical status

    Those who presented in the second trimester

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    22/41

    Management, cont.

    For patients with potentially viable fetuses managedsurgically, steroids were generally administered 24hours preoperatively to speed fetal lung maturation

    Intraoperatively, attention was paid to avoidingelevations in end-tidal CO2 and maintaining volumestatus

    Mothers in their second or third trimester were tilted 15

    to 20 to their left to minimize compression of the IVC,and FHR was monitored by surface ultrasound every 5minutes

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    23/41

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    24/41

    Outcome of medical management

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    25/41

    Relapse rate by trimester of presentation in

    patients managed entirely nonoperatively

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    26/41

    Comparison of outcome after nonoperativeversus operative management

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    27/41

    Outcome of surgical management

    10 patients (13%) with symptomatic cholelithiasis managedoperatively

    8 underwent surgery during the 2nd trimester & 2 during theearly 3rd trimester

    4 patients underwent open cholecystectomy and 6 had lapcholecystecomy

    38 patients underwent surgery in the postpartum period

    Patients who underwent LC were able to tolerate clear liquids0.6 days sooner and regular diet 0.3 days sooner than

    patients who underwent OC No preterm deliveries, relapse of disease after surgery,

    maternal or neonatal ICU admissions or maternal or fetaldeaths

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    28/41

    Conclusions

    Pregnant patients with symptomatic cholelithiasis have ahigh rate of symptomatic relapse during pregnancy

    Relapse rates are similar for patients with BC and AC

    Patients relapse with more severe disease, including CDSand GSP

    Pregnant patients with biliary tract disease should beadvised to consider cholecystectomy for symptomaticdisease

    Surgical management of symptomatic cholelithiasis is safe,reduces the need for labor induction, reduces the rate ofpreterm deliveries and reduces fetal morbidity

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    29/41

    Safety and risks oflaparoscopy in

    pregnancyFozan HA et al: Curr Opin Obstet

    Gynecol 2002, 14:375

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    30/41

    Advantages of Laparoscopy inPregnancy

    General Early return of bowel function Early ambulation Short hospital stay Rapid return to normal activity Low rate of wound infection and hernia Less pain after the operation

    Compared with laparotomy, associated with less fetal depressiondue to reduced narcotic use in the postoperative period

    Minimal manipulation of the uterus while obtaining adequateexposure Less uterine irritability Lower rates of spontaneous abortion, preterm labor, premature delivery

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    31/41

    Disadvantages

    More challenging in the presence of an enlarged uterus

    Possibility of puncturing the gravid uterus with a Verresneedle

    Enlarging uterus displaces intestines out of the pelvis increased risk of bowel or uterine injury by Verres needle,trocar

    Theoretical concern of decreased uterine blood flow due toincreased intra-abdominal pressure and risk to mother andfetus of CO2 absorption

    Clinical safety and efficacy of laparoscopy using CO2 have beenwell documented

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    32/41

    Timing of surgery

    2nd trimester safest time to perform surgery

    Miscarriage rate is 5.6% in 2nd trimester comparedwith 12% in 1st trimester

    Rate of preterm labor in 2nd trimester is very low

    Uterus is still small enough that it does notobliterate the operative field compared with the

    uterus in 3rd

    trimester Theoretical risk of teratogenesis is very low

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    33/41

    Laparoscopic Technique

    Positioning 1st half of pregnancy Dorsal lithotomy position

    2nd half of pregnancy Slight left lateral positioning to

    alleviate impaired venous return Pneumoperitoneum

    Use of nitrous oxide has been advocated; unknownwhether it is safer than CO2

    Helium use in pregnant ewes is associated with less

    incidence of maternal and fetal acidosis Maintaining intra-abdominal pressure less than 12 mm Hg

    and minimizing the length of operative time decreases riskof maternal hypercarbia and fetal acidosis

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    34/41

    Laparoscopic Technique, cont.

    Trocar insertion and placement Due to the enlarged gravid uterus, care should be taken

    with trocar insertion 1 trocar - Inserted using open technique after

    determining height of the fundus Can also be inserted at supraumbilical, subxiphoid midline

    or left upper quadrant Use of an optical trocar allows the surgeon to see tissue

    planes and intra-abdominal organs as the trocar is

    inserted Depending on the height of the uterus, 2 trocars inserted

    higher than those in the nonpregnant condition and underdirect vision

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    35/41

    Placement of trocars for 2nd-trimesterlaparoscopic cholecystectomy

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    36/41

    Tocolytics and Glucocorticoids

    Prophylactic tocolysis not usually needed

    Can be administered if patient experiences

    uterine irritability or contraction Some surgeons administer glucocorticoids

    to women in the late 2nd or 3rd trimester to

    enhance lung maturity

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    37/41

    Fetal Outcome

    Impact of laparoscopic surgery on fetal outcomeevaluated by analyzing the Swedish HealthRegistry from 1973 to 1993

    2233 laparoscopies vs. 2491 laparotomies inwomen with a singleton pregnancy between 4 and20 weeks gestation

    No significant differences in birth weight,gestational duration, intra-uterine growthrestriction, infant death, or fetal malformation

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    38/41

    Biliary Sludge & Pregnancy

    High prevalence of sludge in the peripartum period

    Incidence

    Sludge 26% to 31%

    Gallstones 2% to 5%

    Risk factors

    Sludge No clear risk factors have been identified

    Gallstones Age, obesity and cumulative months of oralcontraceptive use

    Stones and sludge resolve in many women during the firstyear after delivery

    Hypothesized that women with multiple or closely spacedpregnancies may form gallstones as sludge recurs or persists

    Ko CW et al: Biliary Sludge, Ann Intern Med. 1999;130:301

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    39/41

    Biliary Sludge Composition

    Varies with clinicalsituation

    General population

    calcium bilirubinate andcholesterol monohydratecrystals

    Patients receiving TPNprimarily calcium

    bilirubinate

    Pregnancy cholesterolmonohydrate crystals

    Ko CW et al: Biliary Sludge, Ann Intern Med. 1999;130:301

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    40/41

    Causes of Biliary Sludge in Pregnancy

    Greater bile lithogenicity

    Gallbladder hypomotility

    Higher estrogen levels indirectly increasecholesterol saturation of bile

    Higher progesterone levels may inhibit

    gallbladder contractility

    Ko CW et al: Biliary sludge, Ann Intern Med. 1999;130:301

  • 8/4/2019 Cholecystitis & Pregnancy - KSherafgan

    41/41

    References

    Lu EJ et al: Medical vs surgical management ofbiliary tract disease in preganacy, American J ofSurg 2004; 188:755

    Fozan HA et al: Safety and risks of laparoscopy inpregnancy, Curr Opin Obstet Gynecol 2002,14:375

    Ko CW et al: Biliary sludge, Ann Intern Med.1999;130:301